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Abstract
Background: Rates of suicide and accidental or violent death remain high in HIV-positive populations despite significantly
improved prognosis since the introduction of cART.
Methods: We conducted a nested case-control study of suicide and accidental or violent death in the Australian HIV
Observational Database (AHOD) between January 1999 and March 2012. For each case, 2 controls were matched by clinic,
age, sex, mode of exposure and HIV-positive date to adjust for potential confounding by these covariates. Risk of suicide
and accidental or violent death was estimated using conditional logistic regression.
Results: We included 27 cases (17 suicide and 10 violent/accidental death) and 54 controls. All cases were men who have
sex with men (MSM) or MSM/ injecting drug use (IDU) mode of exposure. Increased risk was associated with unemployment
(Odds Ratio (OR) 5.86, 95% CI: 1.69–20.37), living alone (OR 3.26, 95% CI: 1.06–10.07), suicidal ideation (OR 6.55, 95% CI:
1.70–25.21), and.2 psychiatric/cognitive risk factors (OR 4.99, 95% CI: 1.17–30.65). CD4 cell count of.500 cells/mL (OR 0.25,
95% CI: 0.07–0.87) and HIV-positive date $1990 (1990–1999 (OR 0.31, 95% CI: 0.11–0.89), post-2000 (OR 0.08, 95% CI: 0.01–
0.84)) were associated with decreased risk. CD4 cell count$500 cells/mL remained a significant predictor of reduced risk (OR
0.15, 95% CI: 0.03–0.70) in a multivariate model adjusted for employment status, accommodation status and HIV-positive
date.
Conclusions: After adjustment for psychosocial factors, the immunological status of HIV-positive patients contributed to the
risk of suicide and accidental or violent death. The number of psychiatric/cognitive diagnoses contributed to the level of risk
but many psychosocial factors were not individually significant. These findings indicate a complex interplay of factors
associated with risk of suicide and accidental or violent death.
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Introduction
In the era of effective combination antiretroviral treatment
(cART) more than half the causes of death in HIV positive patients
are non-AIDS related [1–5], the most common being non-AIDS
defining cancers, cardiovascular disease and liver disease.
High rates of suicide and accidental or violent death have also
been described in HIV infected populations including in those
receiving effective cART [6–8]. The Data Collection on Adverse
Events of Anti-HIV Drugs (D:A:D) cohort reported suicide as the
cause of death in 4% of deaths, with a further 2.5% attributed to
drug overdose and 1.5% as accident [9]. In CASCADE, suicide
was reported in 6.4% of deaths, violence in 3.3%, and 5.7% of
deaths were attributed to substance abuse [10].
In the early years of the HIV epidemic, poor prognosis was a
key contributing factor to high rates of suicide. Common
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experiences of HIV positive people such as stigmatisation,
discrimination, social isolation, anxiety and depression, as well as
frequent substance abuse, were also identified as contributory
factors to suicide risk. Yet, despite the significant improvement in
prognosis since the introduction of cART the rates of suicide
remain high. This was demonstrated in the Swiss HIV Cohort
Study where rates of suicide decreased substantially in the cART
era compared to the pre cART era but still remained well above
that observed in the general population [6].
In the Swiss HIV Cohort Study, the majority (.75%) of
patients who committed suicide in the cART era had a diagnosis
of mental illness with depression being the most common (.80%).
A significant proportion (23%) of patients who died by suicide in
the cART era had untreated mental illness. In this cohort, suicide
rates were shown to decline with increasing CD4 cell counts.
Advanced clinical stage (using the US Centres for Disease Control
and Prevention classification system [11]) was significantly
associated with suicide risk in both pre- and post-cART eras,
after adjustment for other socio-demographic factors and history
of psychiatric treatment. However, CD4 cell count and other HIV
related factors were not included in this risk factor analysis. In the
Concerted Action on SeroConversion to AIDS and Death in
Europe (CASCADE) study, latest CD4 cell count was not
significantly associated with violent causes of death. As with the
Swiss HIV Cohort Study, the CASCADE study did not assess risk
factors for suicide which take into account both HIV related
factors and general risk factors for suicide in one model.
The extent to which HIV infection is also associated with
increased risk of suicide or violent death is not well documented.
Specifically the relative contribution of HIV related factors such as
immune deficiency, as well as aspects of treatment neuroprotec-
tion/ neurotoxicity (e.g. cerebro-spinal fluid (CSF) penetrating/
non penetrating ART) compared to accepted psychosocial risk
factors has not been described in detail. Recent qualitative models
of suicidality in HIV populations in the post cART era also
incorporate synergistic effects of HIV related factors and ageing
[12].
Most HIV-related studies of suicide focus on suicidality as an
endpoint [13]. This obviates difficulties associated with low
prevalence of suicide cases, case finding and retrospective data
collection. However, there are important differences between
determinants of suicidal ideation and suicide. For example, in a
study of British private households, Gunnell et al found differences
in the risk pattern of suicidal thoughts compared to completed
suicide according to gender and age [14]. In that study the
incidence of suicidal thoughts was seen to be over 200 times
greater than the incidence of suicide. In this study we analysed
determinants of confirmed cases of suicide as well as of accidental
or violent death to develop adjusted models of risk associated with
both psychosocial and HIV-related factors.
Methods
Study Population
The Australian HIV Observational Database (AHOD) is an
observational clinical cohort study of patients with HIV infection
seen at 27 clinical sites throughout Australia. AHOD utilises
methodology which has been described in detail elsewhere [14].
Briefly, data are transferred electronically to The Kirby Institute,
University of New South Wales every 6 months. Core data
variables include: sex; date of birth; date of most recent visit; HIV
exposure; hepatitis B virus (HBV) surface antigen status; hepatitis
C virus (HCV) antibody status; CD4 and CD8 counts; HIV viral
load; antiretroviral treatment data; AIDS-defining illnesses; and
date and cause of death. Prospective data collection commenced in
1999, with retrospective data provided where available.
Ethics approval for the AHOD study was granted by the
University of New South Wales Human Research Ethics
Committee, and all other relevant institutional review boards.
Written informed consent was obtained from participating
individuals. All study procedures were developed in accordance
with the revised 1975 Helsinki Declaration. Further specific ethics
approval was granted for this particular study by the University of
New South Wales Human Research Ethics Committee, and all
other relevant institutional review boards.
Classification of causes of death
The primary endpoint for this study was mortality from suicide
and accidental or other violent causes and has been classified as
‘Unnatural’ cause of death in a previous AHOD study [15].
Collection of data on cause of death in AHOD has been described
in detail elsewhere [3,15]. Briefly, AHOD has collected detailed
information on cause of death (COD) for all deaths occurring since
study inception in 1999: from 2001 until 2002 collected by the
study coordinator via direct contact with relevant sites and
included study participant deaths occurring prior to that period;
thereafter until 2005 using a standardized COD form based on the
Data collection on adverse events of anti-HIV Drugs (D:A:D)
cohort original COD form [16]; and from 2005 using, the more
detailed D:A:D cohort CoDe case report form (CRF) for coding
causes of death and adapted from ICD-10 codes (http://www.
cphiv.dk/Portals/0/files/CRF2012v2.pdf) [17]. Both the initial
COD form and later the CoDe are completed by a clinician at the
study site with details of autopsy reports appended where relevant
and then forwarded to the Kirby Institute for review by AHOD
coordinators. If required, an independent HIV specialist clinician
verifies the primary and secondary causes of death and in cases
where inadequate information is provided to determine the COD,
the study coordinator contacts personnel at the study site for
further information. Patients are classified as having an unknown
COD if no further information is obtained.
For this study, consistency between recorded cause of death and
observed medical records was verified during the site visit by the
AHOD study coordinator at the time of study specific data
collection.
Statistical methods
This study is a nested case control study from those sites with
confirmed cases of suicide and accidental or violent death for
patients consented and recruited to AHOD over the period from
study inception in 1999 until 31 March 2012. For each case 2
controls were randomly selected from AHOD patients matched to
cases by treating clinic, sex, 10-year age group at the time of case
death (‘‘20–29’’/’’30–39’’/’’40–49’’/’’50–59’’) and mode of expo-
sure (‘‘men who have sex with men (MSM)’’/’’MSM and IDU’’/’’
IDU’’/’’ Heterosexual’’/’’Receipt of blood products’’/’’Other’’) to
control for confounder effects. Controls were alive and were HIV-
positive at the time of case death. Mode of exposure was not
included in analyses as an independent predictor, to avoid possible
large discrepancy in empiric distributions of modes of exposure
between cases and controls. This would substantially reduce the
statistical efficiency of analyses incorporating this covariate.
Specific data on possible risk factors associated with suicide or
accidental or violent cause of death was collected using a study
Case Record Form (CRF) by a single AHOD coordinator (HM) at
site visits. An additional 2 case CRFs for 1 site were completed by
site psychologists using medical records and previous study
documents not available at the time of site visit by the AHOD
Suicide and Accidental or Violent Death in AHOD
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coordinator. An additional 1 case CRF and 2 associated control
CRFs for 1 other site were completed by the principal investigator
for that site following determination by the research ethics
committee for that site that the AHOD investigator not be
granted direct access to those medical records. All CRF data was
uploaded to an MS Access database at the Kirby Institute by
electronic form entry.
Specific CRF variables used in this analysis included socio-
demographic and lifestyle factors, specifically: Employment in the
year prior to case death (dichotomised to ‘‘Full time employment
(FTE)’’/’’Not FTE’’); Accommodation in the year prior to case
death (dichotomised to ‘‘Alone’’/’’Not alone’’); Record of prior
suicide attempts (‘‘Yes’’/’’No’’); Recorded alcohol consumption in
the year prior to case death (‘‘No Record’’ (NR)/’’ No
consumption’’/’’Consumption’’); Specified alcohol amount con-
sumed in year prior to case death; Recorded smoking prior to case
death (‘‘NR’’/’’Never’’/’’Currently’’/’’Previously’’); Recorded
recreational/ illicit drug use (‘‘NR’’/’’Never’’/ ‘‘YES-non
IDU’’/’’Yes-IDU’’) and Record of recreational/illicit drug use in
the year prior to case death.
CRF variables also included the incidence (ever and in year
prior to case death) of recorded mental and cognitive and other
risk factors, specifically: suicidal ideation or intent; depression/
anxiety; agitation; dysthymia; bipolar disorder; schizophrenia;
other mood disorders; anorexia nervosa; chronic pain; epilepsy;
and dementia. Data was also collected on recorded psychiatric
medications (type, use ever, use in the year prior to case death).
CRF detail on specific psychiatric, cognitive and other risk
factors was determined and corroborated where possible by
repeated clinician entries in medical records, entries by different
clinicians, by specialist referrals and diagnoses including psychi-
atrist notes and psychologist/counselor notes, and by recorded
prescriptions of associated medications/ therapies.
An aggregated count of mental and cognitive risk factors (‘‘0’’/
’’1–2’’/’’.2’’) was also calculated as the count of first incidence of
these conditions.
Aggregated quantity of alcohol intake (Alcohol) was determined
by ranking reported alcohol consumption quantities for the year
prior to case death and classifying as ‘‘Low‘‘, ’’Moderate’’, ‘‘High’’
or ‘‘Not stated’’. Specifically, ‘‘Low’’ was categorised as up to and
including 3 standard drinks/month, ‘‘Moderate’’ was up to and
including 2–5 standard drinks/night while ‘‘High’’ was all
consumption greater than this. Where there was reported alcohol
consumption without specified quantity of alcohol consumption,
alcohol intake was assigned the median value (‘‘Moderate’’).
Other core HIV related variables routinely collected in AHOD
and included in this analysis were CD4 cell count, HIV viral load,
AIDS defining illnesses (ADI) (‘‘Yes’’/’’No’’) and antiretroviral
treatments (efavirenz, nevirapine, abacavir, stavudine, lamivudine
and ritonavir). The duration weighted use of cART with cerebro-
spinal fluid penetrative effectiveness scores (CPE) greater than the
study median (nerocART) in the year prior to case death was also
included in analyses. CPE scores were based on the 2010 ranks
published by Letendre [18]. NeurocART status was assigned to
regimens with CPE greater than the study median for that year.
Neurocognitive impairment (NCI) was included in analyses
based on medical record of dementia, or detail listing memory loss,
intellectual impariment, encephalopathy or brain damage, or
incidence of HIV encephalopathy/AIDS dementia complex
(ADC) or progressive multifocal leukoenephalopathy (PML)
recorded in AHOD.
Duration weighted average of CD4 cell counts and HIV viral
load values from the year prior to case death as predictors of
suicide risk were used in analyses. These variables might more
accurately model immunological/virological response than using
most recent CD4 cell counts and HIV viral load values.
Specifically, constant rates of change in CD4 cell counts and
HIV viral load values between test dates were assumed over the
interval between consecutive tests and these gradients used to
calculate duration weighted average CD4 cell counts and HIV
viral load values for year prior to case death.
Determinants of suicide and accidental or violent death were
analysed using univariate conditional logistic regression, matching
cases to controls and using the variables listed above as
independent variables. Robust Huber/White variance estimation
was used.
Multivariate analysis was conducted using backward stepwise
selection from the set of significant predictors based on univariate
analyses but was limited by low numbers of observations.
Interaction between covariates was examined using bivariate
interaction models of significant predictors in multivariate models.
A sensitivity analysis investigating determinants of suicide-only
death was conducted using univariate conditional logistic regres-
sion as above. Data were analysed using Stata version 12 (Stata
Corporation, College Station, Texas, USA).
Results
Patient characteristics
A total of 81 patients were included in this analysis – 27 cases
and 54 controls. Of cases, 17 (63%) were classified as death by
suicide with mode of suicide by hanging (5 deaths) and drug
overdose (5 deaths) being the most common (Table 1). A further
10 cases (37%) were classified as violent or accidental death, with
death with associated drug overdose (8 deaths) being the most
common. All cases were male, with a mean age of 41.6 years
compared with 41.1 years for controls. Most deaths occurred prior
to 2006 (61.6%) and mode of HIV exposure was either MSM
(92.6%) or MSM/IDU (7.4%) (Table 1).
Patient characteristics prior to case death are shown in Table 2.
Cases generally recorded higher levels of risk factors for suicide or
violent death. Of social and demographic risk factors, cases were
less likely to be in full time employment (59.3% vs. 35.3%), and
more likely to live alone or in an institutional environment (55.6%
vs. 25.9%). Of mental health, neurocognitive and other medical
risk factors, cases were more likely to have a record of suicidal
ideation (55.6% vs. 20.4%) and to have an increased number of
recorded mental and cognitive and other clinical risk factors (.2
conditions ever recorded (29.6% vs. 11.1%)). Of HIV specific
factors, cases were less likely to have recent CD4 count $500
cells/mL (18.5% vs. 46.3%). Cases were more likely to have been
HIV-positive prior to 1990 (44.4% vs. 22.2%).
Univariate analysis
Factors significantly associated with increased risk of suicide and
accidental or violent death (Table 2) were employment (not in full
time employment (p = 0.005), not stated (p = 0.003)), living alone
or in an institution (p = 0.021), record of suicidal ideation
(p = 0.006) and more than two recorded psychiatric/cognitive risk
factors (p = 0.031)). Factors significantly associated with a reduced
risk of suicide or accidental or violent death were recent CD4 cell
count greater than or equal to 500 cells/ml (p = 0.022) and year
HIV-positive after 1990 (1990–1999 (p = 0.03), $2000 (p = 0.035).
Multivariate analysis
To facilitate fitting of the multivariate model given low numbers
of observations, certain inclusion variables were dichotomised. A
multivariate model was initially fit with recorded recent full time
Suicide and Accidental or Violent Death in AHOD
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employment (FTE) (‘‘Y’’/’’N’’), recorded recent accommodation
status of alone/institution (‘‘Y’’/N’’), psychiatric/cognitive risk
factor count (‘‘#2’’/’’.2’’), year HIV positive (‘‘,2000’’/
’’$2000’’) and duration weighted average CD4 cell count
(‘‘,500’’/’’$500’’/’’Missing’’). Record of suicidal ideation was
excluded from model fitting because of collinearity associated with
prior inclusion of psychiatric/cognitive risk factor count. The
variables retained in the final model were average recent CD4
(p = 0.013), recent full time employment (p = 0.021), recent
accommodation status of alone/institution (p = 0.005) and year
HIV positive (p = 0.004) (Table 3).
Suicide-only death
Low numbers of endpoints prevented detailed examination of
suicide-only death, particularly for non-binary categorical vari-
ables with unreported/missing values. Models were otherwise
qualitatively similar to those developed for the primary analysis
(results not shown). Record of suicidal ideation ever was the only
significant predictor of risk of suicide (OR 7.88, 95% CI 1.44-
43.06, p = 0.020).
Discussion
This study found multivariate association between increased risk
of suicide and accidental or violent death in HIV-positive patients,
psychosocial factors (employment and accommodation status) and
recent immunological status while controlling for age, sex, mode of
exposure, treating clinic and calendar year of HIV diagnosis.
We found an increased prevalence of observed psychosocial risk
factors in cases which reflects well documented prognostic
indicators [7,19]. In particular, employment, accommodation
status and suicidal ideation were associated with increased risk. In
this study previously identified risk factors were not individually
prognostic (alcohol intake, smoking status, recent recreational/
illicit drug use, depression/anxiety, chronic pain and NCI). This is
attributable to insufficient difference in prevalence between cases
and controls for the given statistical power of this analysis. These
results are also consistent with a high prevalence of psychosocial
risk factors in HIV-positive populations in particular, but also in
medically ill populations in general [20-23].
The observed significance of increased number of psychiatric/
cognitive risk factors in analyses is consistent with the exacerbation
of overall risk by cumulative burden of illnesses. Of recorded
psychiatric/cognitive risk factors, only record of suicidal ideation
was statistically significant, however, number of diagnoses of
psychiatric/cognitive risk factors (#2/.2 risk factors) was
prognostic in univariate models. This variable may also more
accurately reflect psychiatric/cognitive status by mitigating specific
omissions or oversights as logged in and obtained from medical
records.
This analysis found a recent CD4 cell count of$500 cells/mL to
be a significant predictor of reduced risk of death by suicide,
violence or accident. This remained significant in multivariate
models after adjustment for socio-demographic factors (employ-
ment and accommodation status). The association of increased
CD4 cell count and reduced risk has been demonstrated by Keiser
et al [24], although that analysis did not adjust for other risk
factors. Our study uses average recent CD4 cell count which
reduces the influence of anomalous or non-characteristic mea-
surements compared to single test values.
Models of suicide risk in HIV-positive populations generally
incorporate complex causal pathways. In particular, psychosocial
risk factors have been shown to predispose patients to non-
adherence [25,26] hence poorer HIV disease control. There are
also reciprocal causal effects of immunological status on severity of
neuropsychiatric symptoms as demonstrated by Warriner et al
[27]. In our analysis there was no evidence of strong interaction
between covariates, although robustness of multivariate models
was limited by statistical power. In these models reduced level of
immunological recovery can be seen to add to the overall risk
associated with just psychosocial factors and may also indicate
comorbidity effects specifically associated with HIV-disease.
We found earlier calendar year of HIV diagnosis to be
associated with increased risk. This study only looks at post cART
era mortality, when improved prognosis has been associated with
some alleviation of psychosocial burden and reduced suicide risk
[24]. However, increased all-cause mortality in HIV populations
has been shown to be mainly attributable to risk factors identifiable
prior to, or at early stages of cART [25]. While our results in part
reflect increased experience of suboptimal therapy amongst high
risk groups, they also suggest that extended duration of infection
increases risk as has been observed in other chronic medical
conditions [28].
Posited mechanisms for suicide risk in HIV-positive populations
include the extent of neuro-protection and neuro-toxicity of ART
Table 1. Characteristics used for case control selection1.
CASE CONTROL
n=27 % n=54 %
Suicide death (n=17)
hanging 5 18.5
drug overdose 5 18.5
wrist cutting 1 3.7
gas inhalation 1 3.7
jump from height 1 3.7
not specified 4 14.8
Violent/accidental death (n=10)
drug overdose (direct or associated) 8 29.6
motor vehicle accident 2 7.4
Gender
Male 27 100 54 100
Age at case death
mean (SD) 41.6 (1.54) 41.1 (1.11)
20–29 1 3.7 2 3.7
30–39 13 48.1 26 48.1
40–49 8 29.6 16 29.6
50–59 5 18.5 10 18.5
Year of Death
1999–2002 11 40.7 – –
2003–2005 7 25.9 – –
2006–2008 5 18.5 – –
2009–2011 4 14.8 – –
Mode of Exposure
MSM 25 92.6 50 92.6
MSM/IDU 2 7.4 4 7.4
1. Controls were also matched to cases by treating clinic and were HIV-positive
prior to case death.
doi:10.1371/journal.pone.0089089.t001
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Table 2. Patient characteristics prior to case death and risk of suicide and accidental/violent death1.
Case Control
n=27 % n=54 % OR 95% CI p p2
Full time employment3 Yes 6 22.2 33 61.1 1.00 - - 0.002
No 16 59.3 19 35.2 5.86 [1.69,20.37] 0.005
Not stated (NS) 5 18.5 2 3.7 28.54 [3.12,261.23] 0.003
Accommodation3 Not alone 7 25.9 23 42.6 1.00 - - 0.021
Alone/Institution 15 55.6 14 25.9 3.26 [1.06,10.07] 0.040
Not stated 5 18.5 17 31.5 0.63 [0.20,1.96] 0.425
Alcohol intake3 Moderate or less 13 48.1 36 66.7 1.00 - - 0.397
High 5 18.5 6 11.1 2.31 [0.46, 11.54] 0.308
NS 9 33.3 12 22.2 1.72 [0.61,4.91] 0.196
Smoking3 Never 11 40.7 18 33.3 1.00 - - 0.284
Prior 2 7.4 10 18.5 0.33 [0.08,1.42] 0.136
Current 12 44.4 25 46.3 0.76 [0.20,2.87] 0.681
Not stated 2 7.4 1 1.9 3.50 [0.25,49.36] 0.354
Recreational/Illicit drug use ever No 4 14.8 4 7.4
Non IDU 10 37 11 20.4
IDU 3 11.1 5 9.3
Not stated 10 37 34 63
Recreational/Illicit drug use3 No 21 77.8 47 87 1.00 - -
Yes 6 22.2 7 13 2.35 [0.64,8.70] 0.200
Suicide attempts No 21 77.8 48 88.9 1.00 - -
Yes 6 22.2 6 11.1 2.73 [0.70,10.69] 0.149
Suicidal ideation No 12 44.4 43 79.6 1.00 - -
Yes 15 55.6 11 20.4 6.55 [1.70,25.21] 0.006
Depression/anxiety No 9 33.3 27 50.0 1.00 - -
Yes 18 66.7 27 50.0 1.87 [0.67,5.25] 0.234
Neurocognitive impairment No 24 88.9 47 87.0 1.00 - -
Yes 3 11.1 7 13.0 0.84 [0.22,3.26] 0.804
Chronic pain No 21 77.8 49 90.7 1.00 - -
Yes 6 22.2 5 9.3 2.68 [0.74,9.68] 0.132
Psych/cognitive risks #2 19 70.4 48 88.9 1.00 - -
.2 8 29.6 6 11.1 4.99 [1.17,30.65] 0.031
Recent psych/cognitive risks3, 4 #2 24 88.9 50 92.6 1.00 - -
.2 3 11.1 4 7.4 1.62 [0.23,11.30] 0.628
Psychotropic medications #2 17 63 42 77.8 1.00 - -
.2 10 37 12 22.2 1.76 [0.61,5.08] 0.297
Recent psychotropic medications3 #2 14 51.9 42 77.8 1.00 - -
.2 13 48.1 12 22.2 2.47 [0.95,6.41] 0.062
AIDS defining illness No 25 92.6 42 77.8 1.00 - -
Yes 2 7.4 12 22.2 0.29 [0.06,1.34] 0.112
AIDS dementia complex No 27 100 51 94.4 1.00 - -
Yes 0 0 3 5.6 Does not
converge
- -
NeurocART5, 6 No 16 59.3 38 70.4 1.00 - -
Yes 11 40.7 16 29.6 1.74 [0.68,4.48] 0.251
CD4 cell count (cells/mL)6 ,500 17 63.0 26 48.1 1.00 - - 0.022
$500 5 18.5 25 46.3 0.25 [0.07,0.87] 0.030
Missing 5 18.5 3 5.6 1.68 [0.33, 8.48] 0.533
HIV viral load (copies/ml)6 #400 11 40.7 30 55.6 1.00 - - 0.291
Suicide and Accidental or Violent Death in AHOD
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although this was not supported by this analysis. In this study the
recent use of neurocART was not significantly associated with risk
in univariate analyses. Generally, there was no association between
risk and neurocognitive impairment although increased observa-
tions are required to support these findings. Similarly, no specific
antiretrovirals were associated with risk of suicide or death by
violence or accident.
In this analysis all observed cases had reported mode of
exposure as ‘‘MSM’’ or ‘‘MSM/IDU’’. This reflects the compo-
sition of the AHOD cohort (.75% of exposures were via these
modes) and of the wider epidemic in Australia, rather than
Table 2. Cont.
Case Control
n=27 % n=54 % OR 95% CI p p2
.400 11 40.7 21 38.9 1.63 [0.61,4.36] 0.368
Missing 5 18.5 3 5.6 3.91 [0.69,22.2] 0.124
First HIV positive result ,1990 12 44.4 12 22.2 1.00 - - 0.04
1990-1999 10 37 28 51.9 0.31 [0.11,0.89] 0.030
$2000 5 18.5 14 25.9 0.08 [0.01,0.84] 0.035
Efavirenz No 20 74.1 49 90.7 1.00 - -
Yes 7 25.9 5 9.3 3.78 [0.96,14.87] 0.057
Nevirapine No 23 85.2 36 66.7 1.00 - -
Yes 4 14.8 18 33.3 0.37 [0.12,1.10] 0.073
Abacavir No 25 92.6 42 77.8 1.00 - -
Yes 2 7.4 12 22.2 0.27 [0.05,1.38] 0.115
Stavudine No 23 85.2 46 85.2 1.00 - -
Yes 4 14.8 8 14.8 1.00 [0.24,4.11] 1.000
Lamivudine No 17 63 28 51.9 1.00 - -
Yes 10 37 26 48.1 0.53 [0.17,1.72] 0.293
Ritonavir No 22 81.5 40 74.1 1.00 - -
Yes 5 18.5 14 25.9 0.66 [0.20, 2.14] 0.488
1. Controls matched to cases by treating clinic, sex, age (10 year age category at case death), mode of exposure, HIV-positive at case death. Univariate conditional
logistic regression used to determine OR.
2. Overall Wald test for categorical variables.
3. Record in year prior to case death.
4. Count of recorded suicidal ideation, depression/anxiety, dysthymia, mood and personality disorders, anorexia nervosa, schizophrenia, neurocognitive impairment.
5. NeurocART regimens are those with CPE greater study median per calendar year of case death.
6. Duration weighted average in year prior to case death.
doi:10.1371/journal.pone.0089089.t002
Table 3. Multivariate conditional logistic regression of determinants of suicide and accidental/violent death1.
Case Control
n =27 % n=54 % OR 95% CI P P2
Full time employment3 Yes 6 22.2 33 61.1 1.00 - -
No/NS 21 77.8 21 38.9 14.25 (1.49, 136.17) 0.021
Accommodation (alone/institution)3 No/NS 12 44.4 40 74.1 1.00 - -
Yes 15 55.6 14 25.9 4.66 (1.59, 13.68) 0.005
CD4 cell count (cells/mL)4 ,500 17 63.0 25 46.3 1.00 - - 0.013
$500 5 18.5 24 44.4 0.15 (0.03, 0.70) 0.016
Missing 5 18.5 5 9.3 2.40 (0.37, 15.44) 0.358
First HIV positive result ,2000 22 81.5 40 74.1 1.00 - -
$2000 5 18.5 14 25.9 0.07 (0.01, 0.41) 0.004
P.chi2 = 0.019, Pseudo R2 = 0.467.
1. Controls matched to cases by treating clinic, sex, age (10 year age category at case death), mode of exposure, HIV-positive at case death.
2. Overall Wald test for categorical variables.
3. Record in year prior to case death.
4. Duration weighted average in year prior to case death.
doi:10.1371/journal.pone.0089089.t003
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necessarily the relative risk compared to other modes of exposure.
In this study, cases and controls were matched on ‘‘MSM’’ or
‘‘MSM/IDU’’ mode of exposure and analyses therefore exclude
confounding effects on risk arising from other modes of exposure
in controls.
Generally, for case-control studies estimated relative risks are
influenced by any causal association with case matching variables.
Age, gender, MSM status and IDU history, which were categories
used for case matching, have well documented association with the
prevalence of general risk factors such as recent drug use, alcohol
consumption, smoking status and psychiatric and cognitive risks.
Given relatively low case numbers, this was an efficient way to
conduct adjusted analyses of epidemic specific and less strongly
associated predictors such as HIV related factors. Our results
however, do not reflect risk associated with different categories of
case matching variables.
This study has a number of limitations. First, primary analyses
were based on suicide and accidental or violent death although
correlates of accidental or violent death potentially differ from
those of suicide only death. In this study, CoDe forms, which
record detail of cause of death, facilitated the use of this endpoint
to capture extra cases with likely similar associated risk behaviours.
Specifically, eight of ten accidental or violent deaths were by
overdose and the associated degree of intentionality could not be
determined. While this may represent some loss of specificity,
there is well documented association between drug use disorders
and completed suicide [29]. Recently Bohnert et al have shown
increased likelihood of US medical examiners to classify overdose
deaths in cases with substance use disorders as indeterminate
intent or unintentional compared to other psychiatric disorders
and suggested that this might therefore indicate misclassification of
suicide deaths for this group [30]. It is also possible that an
additional proportion of accidental or violent deaths are in fact
true suicide deaths but where official pronouncement of suicide
might have been discouraged because of moral and legal
implications [31]. Specifically in this analysis, deaths are very
likely due to suicide or to have associated suicidal ideation. The
increase in statistical power associated with the expanded endpoint
has permitted more detailed analysis than possible by using suicide
only death and should be considered in further analyses.
Second, there is a low absolute number of observed suicide
deaths in AHOD. In this study we examined the expanded
endpoint of suicide to include accidental or violent death and used
efficient statistical methods including a case control design nested
on certain accepted prognostic factors. However, results need to be
carefully interpreted and the chance selection of non-associated
variables in models cannot entirely be discounted. However, it is of
interest that our findings are consistent with other analyses, as
described [7,19,21–24].
Third, there may be site specific differences in comprehensive-
ness of reporting of certain risk factors. For example, certain
treating centres restrict detailing of illicit drug use in patient
records because of possible legal implications. Omitted data is not
expected to introduce bias into analyses because of the case-
control design of the study which matched cases and controls at
the same treating centre.
In conclusion, immunological status of HIV-positive patients
was found to add to the level of risk of suicide and accidental or
violent death after adjustment for psychosocial factors. Number of
psychiatric/cognitive diagnoses contributed to the level of risk but
many psychosocial factors were not individually significant
predictors of risk. These findings indicate a complex interplay of
factors associated with risk of suicide and accidental or violent
death.
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